Academic Health Center
Stay Connected
news-and-notes

U joins national partnership aimed at expanding biopharmaceutical workforce and industry

The University of Minnesota will join a team of academic institutions, private companies, governmental entities and non-profit organizations across the U.S. as a partner for the newly established National Institute for Innovation in Manufacturing Biopharmaceuticals (NIIMBL). NIIMBL, a public-private partnership supported by a $70M investment from the National Institute of Standards and Technology and at least $129M from other participants, aims to transform biopharmaceutical manufacturing in the U.S.

Read more
research-and-clinical-trials

Tunneling Nanotubes: Cellular Highways for Cancer Drug Delivery, Study Suggests

The exceedingly narrow, long offshoots stemming from cancer cells called tunneling nanotubes exchange important cellular cargo vital to sustaining the cells. But new evidence published in Molecular Therapy – Oncolytics shows these tubes may be ideal for distributing cancer-killing viruses, offering a new avenue for cancer treatment.

Read more
expert-perspectives

UMN expert: Sunscreen might not be as effective as you think

The sun is shining and summer has finally arrived. But before heading out for a long day at the beach, a University of Minnesota expert wants you to take a closer look at your sunscreen. A recent Consumer Reports study found 43 percent of sunscreens do not meet the SPF claim on their label and could be putting your skin at serious risk.

Read more
research-and-clinical-trials

Biomarker may predict recurrence in endometrial cancer patients

Endometrial cancer is the most common gynecologic cancer in the U.S.

New research from the lab of Martina Bazzaro, Ph.D., of the Masonic Cancer Center, University of Minnesota and Department of Obstetrics, Gynecology, and Women’s Health, suggests the deubiquitinating enzyme (DUB) USP14 as a promising biomarker for identifying risk of recurrence in endometrial cancer patients.

Read more
expert-perspectives

Expert perspective: California to raise legal age to purchase tobacco from 18 to 21

According to a recent article in Yahoo news, California Governor Jerry Brown approved raising the legal age to buy tobacco for smoking, dipping, chewing and vaping from 18 to 21.

California is hoping that increasing the legal age to purchase tobacco will lower the addiction rate of nicotine. According to Dorothy Hatsukami, Ph.D., a professor in the University of Minnesota Department of Psychiatry who focuses on tobacco addictions and cancer prevention, young people are more susceptible to addictions because their brains are still developing.

Read more
beyond-minnesota

Calling communities to engage in National Cancer Moonshot Initiative

Defeating cancer – a lofty goal, but no more bold than the idea of putting a man on the moon. When President Obama set forth the charge and launched the National Cancer Moonshot Initiative, the scientific community was rallied toward accelerating progress in therapies, diagnosis tools, and prevention tactics.

The NCI is now inviting the public to join the venture, launching a web portal for anyone to come and contribute ideas, concepts, or pathways of study. Many researchers are excited about this partnership with the public and the opportunity for mutual learning and collaboration.

We spoke with Christopher Pennell, Ph.D., associate director for Education and Community Engagement at the Masonic Cancer Center, University of Minnesota, about this new step in the Moonshot Initiative.

Read more